C

Cadrenal Therapeutics Inc
NASDAQ:CVKD

Watchlist Manager
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Watchlist
Price: 13.54 USD 1.58%
Market Cap: 26.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CVKD Price Targets Summary
Cadrenal Therapeutics Inc

Wall Street analysts forecast CVKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVKD is 36.38 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

CVKD Lowest Forecast
Wall Street Target
30.3 USD
124% Upside
CVKD Average Forecast
Wall Street Target
36.38 USD
169% Upside
CVKD Highest Forecast
Wall Street Target
47.25 USD
249% Upside
Lowest
Price Target
30.3 USD
124% Upside
Average
Price Target
36.38 USD
169% Upside
Highest
Price Target
47.25 USD
249% Upside
Cadrenal Therapeutics Inc Competitors:
Price Targets
4523
Eisai Co Ltd
32% Upside
600216
Zhejiang Medicine Co Ltd
14% Upside
ERIS
Eris Lifesciences Ltd
6% Upside
C
000661
Changchun High & New Technology Industries Group Inc
6% Upside
4523
Eisai Co Ltd
32% Upside
600216
Zhejiang Medicine Co Ltd
14% Upside
ERIS
Eris Lifesciences Ltd
6% Upside
C
000661
Changchun High & New Technology Industries Group Inc
6% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
71% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
12% Upside
C
570
China Traditional Chinese Medicine Holdings Co Ltd
23% Downside
600535
Tasly Pharmaceutical Group Co Ltd
0% Downside

Revenue
Forecast

Revenue Estimate
Cadrenal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cadrenal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cadrenal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
CVKD intrinsic value, competitors valuation, and company profile.
DCF Valuation
CVKD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CVKD stock valuation using valuation multiples.
Wall Street Estimates
CVKD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CVKD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CVKD's stock price target?
Price Target
36.38 USD

According to Wall Street analysts, the average 1-year price target for CVKD is 36.38 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.